Respiratory physiotherapy and rehabilitation are important therapeutic options in non-cystic fibrosis bronchiectasis (NCFB). The aims of this review of clinical trials were to evaluate the safety and the effects on physiologic and clinical outcomes of airway clearance techniques (ACTs) and rehabilitation in NCFB patients, in comparison to usual care. The search was performed on March 2018 by using PubMed and PeDro databases. 33 studies were selected. The use of ACTs for NCFB were effective in increasing sputum volume although no benefit in quality of life (QoL) or pulmonary exacerbations were observed. There were no differences in effectiveness between the several techniques used. Humidification and saline inhalation were able to aid airway clearance. Hypertonic solution (HS) was more effective than isotonic solutions (IS) in improving expectoration and sputum viscosity. Pulmonary rehabilitation (PR) was found to be associated with short term benefits in exercise capacity, dyspnea and fatigue. Exercise training seems to improve quality of life and lower exacerbation rate, but long-term data are not available. Further studies are necessary to identify the most feasible long-term outcomes such as QoL and exacerbation rate.
Introduction
Bronchiectasis is an irreversible and progressive condition of the airways characterized by the presence of bronchial walls dilatation due to alterations in their structure. They may be congenital or more frequently acquired, secondary to a wide variety of conditions including lung infections, as severe pneumonia following measles, pertussis and tuberculosis. Chronic fibrous lung diseases such as those following abnormal pneumonia or inhalation of foreign bodies, harmful gases or particles, also predispose to the development of bronchiectasis. Congenital diseases such as cystic fibrosis, primitive ciliary dyskinesia, α-1 antitrypsin deficiency, and immunodeficiencies can also result in bronchiectasis [1] .
Bronchial walls dilatation usually involves segmental or subsegmental bronchioles, and can spread to one or more pulmonary lobes. These anatomical alterations combined with reduced airway clearance expose patients to the risk of bacterial colonization and recurrent infections [2] ; the latter, in association with a chronic inflammatory reaction, can cause further airway damage, triggering a vicious circle. The small airways may also be involved as a consequence of proximal obstruction. In fact, in advanced stages of the disease peripheral spaces dilatation and deteriorated respiratory function are also present [3] .
Patients with bronchiectasis may have heterogeneous clinical manifestations as repeated bronchial exacerbation episodes, with or without fever, increased cough and mucus production, hemoptysis, and daily production of significant amounts of mucus secretions. Some patients may have dry cough, with little or no expectoration. Bronchiectasis may be associated with other symptoms such as dyspnea, chest pain, fatigue, reduced exercise tolerance and reduced life expectancy [4] [5] [6] . Advanced stages of disease progress to the development of chronic respiratory failure and cor pulmonale-related heart failure [7] .
Treatment of bronchiectasis is multifaceted and aims to control symptoms, improve life expectancy, prevent progressive pulmonary
Results
We identified 126 potentially relevant articles. Of these, 99 were excluded after the abstracts were read.
Finally, 33 studies were included in this review: 27 were found from primary searching and the others identified among the references. The process for selecting studies and exclusion criteria are displayed in Figure 1 .
A total of 33 articles were included as they addressed the three main areas of intervention: tracheo-bronchial clearance (20 studies), airway humidification and saline inhalation (6 studies), and exercise (7 studies).
Bronchial airway clearance
ACTs are now recommended in bronchiectasis aimed at improving airway clearance [9] [10] [11] . Only in recent years we have witnessed a gradual increase in specific studies on NCFB.
The first studies were focused on the direct comparison of two main techniques: Oscillatory Positive Expiratory Pressure techniques (O-PEP) (Flutter and Acapella), and controlled breathing techniques [Active Cycle of Breathing Technique (ACBT)] and Breathing Control (BC) with or without posture changes ( Table 1) . Three crossover studies [12] [13] [14] , and 2 RCTs [15, 16] have showed similar outcomes in respiratory function parameters and sputum weight. There were no significant differences in efficacy between the techniques proposed, both in acute [15, 16] and chronic patients [12] [13] [14] . In a single study the forced expiratory volume in 1 s (FEV1) improved with flutter (p<0.03) [12] ; in another study ACBT associated with posture changes was associated with improved secretions drainage than flutter [14] . Several studies have found that O-PEP device was the preferred technique both in chronic (in 65%, 70% and 44%, respectively) [12] [13] [14] and in acute patients, because it was considered more effective (Flutter vs BC p=0.011) [15] . However, no statistically significant difference in tolerance and duration of treatment was observed (Acapella vs ACBT p<0.06) [16] . The main limitations in comparing the results of these studies are the use of different scales for subjective measurements (chronic respiratory questionnaire (CRQ), Borg dyspnea, visual analogic scale (VAS), Likert Scale). Also, different application techniques time ranging from single daily treatment to twice or more times per day, for a total time that never exceeded 4 weeks have been used [13, 14] .
In 2009, Murray proposed a three-month crossover study to evaluate the effectiveness of regular chest physiotherapy [17] . There was a significant difference in medium to long term sputum volume using Acapella twice per day compared to the group not treated with airway clearance. The increase in the sputum volume was associated with higher exercise tolerance (Incremental Shuttle Walking Test (ISWT) p<0.001) and improved quality of life (QoL) [Leicester Cough Questionnaire (LCQ) p<0.002, Saint George Respiratory Questionnaire (SGRQ) p<0.005]. However, there were no spirometric parameters and number of exacerbations improvement.
Guimarães performed a crossover-controlled study [18] , and although there was a single treatment session for each technique (Expiration Lente Totale Glotte Ouverte en infraLateral (ELTGOL) and flutter), static volumes significantly decreased after only 15 minutes compared to the control group in the treatment with ELTGOL [total lung capacity (TLC) 9.66%, Functional residual capacity (FRC) 14.48%, residual volume (RV) 18.72%) and with Flutter (TLC 18.27%, FRC 25.81% and RV 29.55%]. The authors concluded that these techniques were equally useful in reducing the degree of hyperinflation in obstructive syndromes. Moreover, the ELTGOL technique allowed faster secretions drainage than the flutter did (p<0.05). The first study of long-term effectiveness of ELTGOL in cleaning secretions was described in a recent randomized placebo-controlled trial [19] . Performance of the Review N o n -c o m m e r c i a l u s e o n l y ELTGOL technique twice-daily over a 1-year period increased overall 24-h sputum volume (during first intervention and 24 h later) by 17 mL compared to placebo (p≤0.001). The trial reported lower exacerbation rate (p=0.042), an improvement in QoL (SGRQ p<0.001), and a reduction in the impact of coughing (LCQ p<0.001). This study is the first long-term randomized controlled trial of an ACT. Finally, two recent studies have analyzed the efficacy and comfort of ACBT compared to postural drainage (PD), concluding that there were no significant differences in sputum volume [20] ; nevertheless, ACBT was the preferred technique [21] .
Several studies have analyzed the use of alternative techniques to enhance airway clearance ( Table 2) . Naraparaju compared Acapella with an Inspiratory Muscle Training instrument (IMT), concluding on the superiority of the O-PEP device with a sputum amount of 7.16 ±1.12 mL vs 6.4±1.08 ml (p=0.014) [22] . A study on a population of 78 patients with chronic obstructive pulmonary disease (COPD) and 20 with bronchiectasis evaluated the efficacy of temporary PEP (T-PEP) on several outcomes. A statistically significant improvement in inspiratory capacity (IC) was observed in the T-PEP group compared to the control group, in which only manual techniques were performed [23] .
Limitations in this study were the treatment time (20 min for manual treatment vs 20 min + 15 min for the T-PEP group) and population data (bronchiectasis patients were not described separately in the study). Herrero-Cortina et al. [24] investigated the efficacy of T-PEP compared to other manual techniques [autogenic drainage (AD) and ELTGOL] in a more homogeneous group of patients. The authors emphasized the equal effectiveness of the three techniques in draining secretions over 24 h after physiotherapy. Furthermore, a progressively lower production of sputum in daily life compared to baseline (p<0.001) was observed. Whereas AD and ELTGOL were associated with faster sputum drainage, sometimes within the same session, T-PEP appeared capable of generating a constant drainage, even after the application. The study of D'Abrosca et al. [25] confirmed the efficacy of T-PEP on pulmonary function parameters. The author additionally observed a reduction in oxygen requirement among patients on long-term oxygen therapy compared to the group treated with PEP Mask.
A recent RCT investigated the short-term efficacy of high frequency chest wall oscillation (HFCWO). HFCWO applied for 30 min twice per day at a frequency of [13] [14] [15] Hz was compared with a commonly used ACTs (PEP, ELTGOL) and with medical therapy alone (control group). Both active treatment groups were associated with a significant increase in the amount of sputum, and a reduction of symptoms and scores related to health status in comparison to the control group. Direct comparison between the two active treatment groups demonstrated the superior efficacy of HFCWO in reducing inflammatory parameters, and in improving forced vital capacity (FVC) and FEV1 [26] .
In another study, intrapulmonary percussive ventilation (IPV) was compared with conventional therapy: PD and forced expiration technique (FET). In both groups there was no significant change in oxygen saturation, whereas a reduction of respiratory rate, an improvement in dyspnea and an increased amount of sputum were observed in the group treated with IPV [27] .
Furthermore, four crossover studies (Table 3) analyzed the direct mechanical effects of O-PEP on mucus and airway resistance. Valente [28] investigated the effect of oscillating waves comparing the flutter with a "sham flutter" obtained by removing the metal ball and partially blocking the holes to maintain the PEP effect. There were no significant changes in the displacement velocity and mucosal adhesion after 20 and 40 minutes of treatment. Other recent studies have used sham flutter as a method of comparison, with different results from the former study. Tambascio highlighted that mechanical oscillations were able to modify mucus rheology by reducing adhesive strength (p<0.05) [29] . Figueiredo manual percussion and forced expiration with open glottis (HUFF) might be effective in improving the drainage of viscous-elastic secretions, but only after application times longer than 60-90 min [31] .
Interventions aiding airway clearance
In current clinical practice, humidification and saline (isotonic 
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Humidification
In 1992, Conway [32] published a study evaluating airway clearance by radio-marking aerosol after a session of cold humidification with sterile water. Significant results were found for sputum weight (p<0.05) and radio-marking clearance (p<0.05).
More recently, several studies have evaluated the effects of warm air humidification in subjects with bronchiectasis (Table 4 ). In the first observational study, 14 patients were enrolled for 7 days of home-warming humidification lasting 3 h a day, with a high-flow system that supplied water vapor air at 37°C at a flow of 20 to 25 l/min through a special nasal-cannula. The study measured tracheobronchial clearance through the retention of a radioactive tracer monitored at 6 and 24 hours, and assessed pulmonary function. After the treatment, an increase in mucosal clearance was observed (p=0.007) [33] .
In 2012, Rea and colleagues [34] evaluated the effects of one year-treatment using the same high-flow system from the former study. They recruited 108 patients, including 73 patients with COPD and 45 with bronchiectasis. The treatment group performed active humidification using high flow nasal cannula (HFNC) 2 h per day, the control group received usual care according to Australian-Asian guidelines [35] . There were no statistically significant differences between the two groups in the exacerbation rate, number of admissions, distance walked during 6 minutes walking test (6MWT) and inflammatory markers; whereas statistically significant differences were found in the total days of exacerbations, number of subjects who did not show exacerbations, FEV1 and FVC at 6 and 12 months, antibiotic therapy consumption, and SGRQ scores.
Inhalation of nebulized saline solution
In the study published by Kellett and coll. four interventions with different humidification techniques and timing were compared. Saline solutions, isotonic solution (IS) and hypertonic solution (HS), have proved to be significantly more effective in increasing sputum amount, reducing viscosity, and facilitating expectoration compared to ACBT alone. HS was significantly more efficient than IS regarding the weight of produced sputum, viscosity and ease of sputum production [36] .
Subsequently, the same authors conducted a crossover study that lasted 9 months comparing the use of IS at 0.9% to HS at 7%. A significant improvement in FEV1 (p<0.01) and FVC (p<0.01) in the hypertonic treatment phase compared with the isotonic control phase was observed. Significant differences were found for SGRQ global score and in domains of symptoms and impacts (p<0.05), but not for domain activity. A retrospective analysis found a lower use of antibiotics (p<0.05) and number of exacerbations (p<0.05) in the active phases of the study compared to the period prior to the study [37] . An RCT compared the use of HS at 6% with the use of IS at 0.9% twice per day for a period of 12 months. A daily diary was used to record patient adherence, changes in medical therapy, and symptoms (differences in sputum color or volume, hemoptysis, coughing, dyspnea, lethargy, fever or nasal secretions). There was no statistically significant difference at 3, 6, and 12 months between the two groups [38] .
Physical exercise
Some studies have investigated the role and effectiveness of specific muscle training programs and/or respiratory muscle training in bronchiectasis patients ( Table 5 ).
Newall examined the effects of a non-specific training program, with and without the combination of IMT, on exercise tolerance and QoL versus control group only involved in educational meetings. A significant increase in ISWT in both sham (PR-SHAM) and intervention (PR-IMT) groups (96.7 m and 124.5 m respectively) compared to baseline was observed after 8 weeks without significant differences between the two groups. Significant improvement in the strength of respiratory muscles was observed, with an increase in maximal inspiratory pressure (MIP) in both groups who performed training, without significant differences between the two groups (p=0.22). There was no improvement in the peak maximal oxygen uptake (VO2 max) in any of the three groups. At three months follow-up evaluation, improvement in exercise capacity was maintained only in the PR-IMT group compared to PR-SHAM group (p=0.01). Also, SGRQ significantly improved in the PR-IMT group compared to the control group (p=0.05). Conversely, in the PR-SHAM group there was no significant improvement in QoL despite the improvement in exercise capacity. Finally, no significant changes in the sputum volume were observed in any of the participants [39] .
To confirm that the same chest rehabilitation programs used in COPD patients are effective also in patients with bronchiectasis, Ong [40] retrospectively compared the effects of the same outpatient retraining program performed in patients with bronchiectasis and in patients with COPD. At the end of an eight-week rehabilitation program, a significant improvement in the 6MWT (53-meter average increase) and in the CRQ (average change of 14.0 units) was observed in the bronchiectasis group. This positive effect was also significantly higher than the baseline at one year (20.5-meter average increase for 6MWT increase and 12.1 points at CRQ) and did not differ from those found in the COPD patients' group. Another retrospective study [41] showed significant improvement in vital capacity (VC) and a significant reduction in RV in 41 patients with bronchiectasis (7 with Cystic Fibrosis) after a 12-week training program, although the increase in the 6MWT did not show significant variations. The authors demonstrated that physical exercise was not contraindicated, and developed functional benefits, also in severely obstructed patients (mean FEV1 44% of predicted). They suggested a lack of improvement in the 6MWT due to the fact that enrolled subjects had a high baseline exercise tolerance (mean distance covered 425 m). Oher comments from the same study were that the design of training programs for bronchiectasis patients should differ from those for patients with COPD in terms of intensity, frequency and duration of sessions. A high-intensity training program (workload achieving a heart rate of 70-80% of the maximum reached at 6MWT and a Borg dyspnea score of 3-5) was implemented in another retrospective study. A significant improvement in the 6MWT, QoL and dyspnea reduction [42] was observed.
Review
Two further studies have compared training programs in addition to ACTs [43, 44] . In the study published by Mandal et al. [43] , 30 patients with clinical stability and purulent or mucopurulent expectoration who performed regular airway clearance sessions were randomized into two groups: a control group performing bronchial airway clearance twice a day, and a treatment group, which added a three weekly training session. At the end of the study, there was a significant improvement in the treatment group: ISWT and endurance walk test (EWT) increased 56.7m (p=0.03) and 193.3m (p=0.01) respectively. Furthermore, QoL questionnaires were improved: LCQ increased by 2.6 units (p<0.001) and SGRQ by 8 units (p<0.001) in the training group. No improvement was observed in the control group that only performed bronchial airway clearance sessions with Acapella. Even at 20 weeks, 3 months after the end of training, the improvement was only present in the intervention group, with an increase in the ISWT (80mt, p=0.04), EWT (247.5mt, p=0.003), LCQ score (4.4 units, p<0.001), and SGRQ score (4 units, p<0.001). The second study [44] which compared the effects of a training program in addition to usual ACT, evaluated the short and long term effects on the capacity to sustain exercise, QoL, and the incidence of exacerbations. The study involved 85 clinically stable bronchiectasis patients with dyspnea ≥ 1 according to the modified Medical Research Council scale (mMRC) and a history of two or more exacerbations per year which required antibiotic therapy in the two years previous the study. At the end of the 8-week treatment, the improvement in the distance walked on ISWT (average difference of 62 m) and 6MWT (mean difference of 41 m) was higher in the treatment group than in the control group. This effect was lost at 6 and 12-month follow-up. In the exercise group, there was also a reduction in dyspnea (p=0.009) and muscle fatigue (p=0.01), but no significant improvement in CRQ, LCQ and psychological conditions [hospital anxiety depression scale (HADS)]. Among the long-term results, a significant reduction in the number of exacerbations was observed at 12 months in the treatment group compared to the control group (p=0.012). A single study, Liaw et al. [45] evaluated the feasibility and effectiveness of a respiratory muscle training program. At the end of the study, only a significant MIP improvement (mean -25.3 versus -16.4 cmH2O, p=0.005) and maximal expiration pressure (MEP) (mean +30.8 versus +20.8 cmH2O p=0.038) were observed in the treatment group.
Discussion
Bronchial airway clearance
ACTs are physiotherapy interventions designed to facilitate the removal of tracheo-bronchial and lung secretions. In clinical practice, a large number of single or combined techniques based on different intervention strategies are used: positioning, pulmonary volume and expiratory flow changes, application of positive expiratory pressure, vibration, airway oscillations and chest wall oscillations [46, 47] .
Although some guidelines recommend the use of chest physiotherapy [7, 9] and there is consensus in the literature over the associated improvements in symptoms and QoL [48] [49] [50] , its effectiveness has not been clearly demonstrated in patients with bronchiectasis.
The difficulty in determining its efficacy is related to disease heterogeneity, linked to individual variability in daily sputum volume, the magnitude of ventilatory limitation and degree of obstruction, and the severity of respiratory symptoms [1, 7, 8, 46] .
The majority of the published studies show several methodological limitations that can affect their results. Most studies had a small sample size and a crossover design [12, [16] [17] [18] 22, [27] [28] [29] [30] . Only three studies compared an airway clearance technique with a placebo (sham therapy) [19, 29, 30] and only three studies had a control group that did not perform any treatment, other than medical therapy [17, 18, 26] .
One of the mayor difficulties in evaluating the effectiveness of ACTs lies in selecting appropriate outcome measures that accurately reflect therapeutic effects, such as improved mucus transport, or secondary effects of mucus removal as frequency and the duration of exacerbations, hospitalization days, changes in respiratory function and QoL. Secretion removal is often evaluated by measuring the volume of sputum produced. This evaluation may be highly influenced by factors as inhibition of the patient expectoration, secretions swallowing, etc. In the studies we have analyzed, the sputum was significantly increased in the following treatments: ACBT + PD compared to Flutter [14] Flutter versus sham-Flutter [29] , Acapella compared to no treatment [17] or IMT [22] , ELTGOL compared to placebo [19] , and HFCWO compared to conventional or no treatment [26] . Spirometric parameters are frequently used as short-term outcome, although there are some limitations in using them. The presence of secretions may have different effects depending on the level of obstruction. Secretions may worsen obstruction by reducing the expiratory flow in the small airways, whereas complete airway obstruction can lead to a reduction in lung volumes. FEV1 was seldom significantly modified [12, 23, 26] despite all studies having considered spirometric measures. The study of Guimarães et al. suggested a correlation between sputum quantity and a static volume improvement [18] . Nevertheless, this data was applicable only to the bronchiectasis phenotype with detectable dynamic hyperinflation. It is therefore difficult to find changes in these parameters if a small number of patients are analyzed. Finally, the effect of airways clearance programs on QoL has been analyzed in two studies [17, 19] which demonstrated an improvement in cough, an improvement in the psychological /social impact, an improvement of exercise tolerance and a reduction of exacerbation rate. The distinguishing feature of the study performed by Munoz [19] relative to other randomized clinical trials was the longer duration of intervention.
This should open a debate as to what is the most clinically relevant endpoint to measure the effectiveness of airway clearance ( Table 6 ).
Interventions aiding airway clearance
Conway and Hasani [32, 33] observed an improvement in mucociliary clearance after using sterile water nebulization and warm humidification with a high flow system. Regarding the long-term use (12 months), a single study [34] reported a statistically significant improvement on the exacerbation rate, and lung function at 6 to 12 months. There was a decrease in antibiotic therapy. Also an improvement of QoL measured by SGRQ in all domains, except for activity was observed. The results of this study, however, have to be considered with caution, since the patients population included 73 COPD and 45 bronchiectasis subjects without separated analysis performed.
Concerning saline nebulization, we found a statistically significant improvement in sputum volume, in ease and viscosity of sputum clearing with HS (7%) compared to IS [36] . Moreover, with HS (7%) improved FEV1 and FVC, QoL (except for domain activity), and lower use of antibiotic therapy and number of exacerbations were observed [37] .
Very different results, however, were reported by Nicolson [38] who demonstrated no significant improvement in QoL, respiratory function, number of exacerbations or changes of sputum colonization by comparing the use of IS and HS at 6% for 12 months with two nebulizations per day.
Physical exercise
In bronchiectasis as in other respiratory conditions, especially in the most advanced stages, the combination of bronchial obstruction and pulmonary hyperinflation may worsen dyspnea and result in reduced tolerance to physical exercise and QoL [5, 51, 52] .
All studies in which physical exercise training was performed have clearly demonstrated short-term improvements in the ability to sustain exercise, with reduced dyspnea and fatigue [39] [40] [41] [42] [43] [44] 53] . This effect was comparable to those reported in COPD patients treated with similar programs [7] .
Studies showing also long-term results have observed different results. Improvement in the ability to sustain physical exercise was maintained at the 3 month-follow-up in the studies of Mandal [43] and Newal l [39] , and at one year follow-up in Ong's study [40] . However, this effect was not maintained after 6 and 12 months in Lee's study [44] .
Long term results regarding QoL are also different: in the Newall's study [39] the improvement in QoL measured with SGRQ at the end of treatment persisted at 3 months; otherwise, QoL in Ong's study [40] (measured with the CRQ) and Mandal's study [43] (measured with LCQ and SGRQ) showed improvement at the end of the program, and the benefits were maintained at 20 weeks and 12 months, respectively. In the study performed by Lee [44] , even if physical exercise reduced dyspnea and fatigue, no changes were observed in LCQ and HADS. These findings suggest that this type of intervention should include maintenance programs useful in modifying patient lifestyles for long-term benefits. Moreover, an important emerging issue in the long-term follow-up, as demonstrated by Lee's study [44] , is a lower incidence of exacerbations in subjects participating in a full pulmonary rehabilitation program compared to the group who only performed airway clearance.
The training of respiratory muscles in patients with bronchiectasis is feasible and seems to improve the strength of respiratory muscles as already demonstrated in COPD subjects. Nevertheless, if it is performed without the addition of a physical exercise program, is incapable to improve short term respiratory function and QoL [44] . It has been shown that a respiratory muscle training associated with lower limb muscle training can affect the distance maintenance obtained with a physical exercise program and improve the QoL [39] .
Exercise may play a role in favoring mucus expectoration [54] , but such observations were not confirmed in the study of Newall [39] . The author found no significant changes in sputum volume in subjects who performed high intensity exercise, nor in the group who added lower limb muscle training to a respiratory muscles training program. Unfortunately, other studies comparing bronchial airway clearance programs with the addition of peripheral muscle training did not insert sputum amount between the outcome measures. Therefore, this observation cannot be confirmed nor denied.
It is unclear whether individual bronchial airway clearance programs may play a role in improving the ability to enhance physical exercise, and reduce dyspnea and fatigue [46, 48] . Some studies did not find any improvement in dyspnea scales (VAS or Borg) after an airway clearance session [12, 13, 16] , whereas other studies have showed improvements in ISWT [17] , mMRC [20, 26] and breathlessness, cough and sputum scale (BCSS) [26] . The paucity of information is obviously due to the fact that the ability to perform physical exercise is not a primary outcome in airway clearance programs.
So far, studies on training programs in patients with bronchiectasis are few and far from homogeneous in design and management. Patients have not been selected in relation to clinical severity clusters, type, intensity, frequency. Furthermore, the duration of individual sessions has been variable and outcomes not always comparable. New studies are therefore desirable to provide clearer guidance on the essential components and the most effective ways of conducting specific training programs for patients with bronchiectasis.
Limitations
This review has some limitations. First, quality and weigh of the various studies have not been evaluated. Second, the heterogeneity across the selected studies may have affected the results of the review. However, the high number of records may give further hints on the effects of the various interventions.
Conclusions
Bronchiectasis represent the result of confluent factors involving infectious, genetic, autoimmune, evolutive and allergic components. Etiology, clinical manifestations and prognosis may be very heterogeneous [8] . This scenario makes it difficult to individualize the best outcome in terms of physiologic and or clinical benefit for non-cystic fibrosis bronchiectasis patients.
ACTs seem effective in increasing sputum volume although no benefit in QoL or exacerbation rate have been shown. There were no differences in effectiveness between several techniques used. From our point of view, ACTs should also be accompanied by global rehabilitation interventions involving educational aspects in the management of the disease. Proper management of medical therapy and early recognition of exacerbations, linked to endurance training programs should be included. PR has been associated with short term benefits in exercise capacity, dyspnea and fatigue. Exercise training might improve QoL and exacerbation rate, but long-term data are not available. No adverse effects were described. All treatments were well-tolerated.
As emphasized by the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC), physiotherapy and respiratory rehabilitation are the major topics of research in the field of bronchiectasis. Further studies are needed to optimize compliance, access to bronchial airway clearance and physical exercise training [55] .
In particular, future studies should include significant clinical outcomes as the number of exacerbations, access to medical assistance, and improvements in QoL. Patients selection should also be oriented towards a better stratification and should take associated comorbidities into account. 
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